In Focus

Low government funding has affected the quality of healthcare in public hospitals.

The country's science agency opened a new national lab in Melbourne.

An elevated demand for prescription drugs has held back demand for OTC drugs.

The country is still in the nascent stage of developing these therapies.

Diabetes made up the largest share of healthcare costs.

More than half relied on home remedies instead of seeking medical help.

The world's top 20 pharma firms can gain $300m a year using advanced analytics.

The country is expected to remain keen to lessen pharma import dependency.

The country’s pandemic landscape is expected to transform further in the coming months.

The structural shift in the country’s healthcare system has been influenced by tech.

But Fitch Solutions’ report noted that allocation for medicine investment remains low.

The country’s new national medical devices policy is expected to reduce import reliance.

India's weak IP laws could be an issue for drug manufacturers in Australia.

The firm expects telemedicine adoption to grow through 2024.

Most Western countries reduced imports of medical devices to Russia.

New insulin products will also boost the market.